Sjogrens Flashcards
Confirming Dx of Sjogren’s? (4)
- Schirmer test (test for dry eyes): filter paper applied to margin of lower eyelid → wetting <5mm
- Salivary gland hypofunction - e.g. scintigraphy or sialometry
- Anti Ro/SSA and La/SSB
- If dx unclear, consider Salivary gland biopsy (look for extensive lymphocytic infiltration with glandular/ductal atrophy)
What are the extra-glandular features of Sjogren’s syndrome? (5)
Most important for long case
- ILD (NSIP, UIP, COP)
- Renal (most common = tunulo-interstitial nephritis, 25-50%)
- Transverse myelitis or NMO (many have Aquaporin Abs)
- Peripheral neuropathy
- NHL (x40 risk) - and other cytopaenias
Others include
Skin: Xerosis (abnormal dryness), cutaneous vasculitis
Arthralgia & arthritis
GIT/Biliary - dysphagia, nausea, celiac
Heart: CV disease
What is the most common cause of secondary Sjogren’s? (1)
Non-pharmacological Mx of Sjogren’s?
-
Educate: self-care of sicca symptoms [eye/mouth] is the key.
- Artificial tears: regular
- Tear conservation: avoid windy/dry outdoors, use humidifiers, wraparound sunglasses
- Artificial saliva (pilocarpine in resistant cases), oral hyginen, hydration, avoid sugary fluids, carbonated drinks, regular dental appointments
So regular dental + ophthal F/U
- Immunisation
- Smoking cessation (worsens dry mouth, inc risk of CVD, diminishes efficacy of HCQ)
- Diet and nutrition: dietry FA supplements - omega-3
- Counsel on Pregnancy (risk of congenital heart block) - refer to perinatologist & surveillance for CHD
Pharmacological Mx of Sjogren’s - general approach?
For sicca symptoms, generally does not require systemic ImmSx.
Indicated in organ-based disease + consititutional symptoms - skin rashes, arthritis, pulmonary, renal.
Approach is similar to that of SLE and RA
- Steroids - severe glandular or extraglandular disease
- Hydroxychloroquine
- DMARDs: MTX, Leflunomide, AZA, sulfasalazine, MMF
- ImmSx: CsA, Tac, Cyclophosphamide, Rituximab.
Prognosis of Sjogren’s?
Extraglandular involvement is associated with a reduced quality of life, and some evidence has suggested that Sjögren’s syndrome (SS) is associated with increased mortality compared with matched controls.